Related Experiment Video
Updated: Jul 26, 2026

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes
M L Reitman1, M M Mason, J Moitra
1Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. mlr@helix.nih.gov
Annals of the New York Academy of Sciences
|June 8, 2000
Summary
Lipoatrophic diabetes, a rare condition of adipose tissue deficiency, contrasts with obesity-associated diabetes. Transgenic mouse models reveal insights into the mechanisms of this fat-deficiency diabetes and related metabolic syndrome features.
Area of Science:
- Endocrinology and Metabolism
- Genetics and Molecular Biology
Background:
- Lipoatrophic diabetes is a rare human syndrome characterized by adipose tissue deficiency, Type 2 diabetes, hypertension, and dyslipidemia.
- This condition presents a unique contrast to obesity-associated diabetes, offering a model to study diabetes mechanisms and complications.
- Metabolic Syndrome X features are often observed in patients with lipoatrophic diabetes.
Purpose of the Study:
- To review and compare murine models of fat ablation with human lipoatrophic diabetes.
- To investigate whether fat deficiency is causative of diabetes and elucidate the underlying mechanisms.
- To explore mechanistic explanations for associated clinical features and potential treatment insights.
Main Methods:
- Review of recently developed transgenic mouse models deficient in white adipose tissue.
- Comparison of clinical and metabolic phenotypes between murine models and human lipoatrophic diabetes.
- Analysis of the relationship between fat deficiency, insulin resistance, and metabolic syndrome features.
Main Results:
- Transgenic mice lacking white adipose tissue exhibit insulin resistance and lipoatrophic diabetes features, serving as faithful models.
- These models facilitate the study of diabetes causation by fat deficiency.
- The models aid in understanding the mechanistic basis of hypertension and dyslipidemia in this syndrome.
Conclusions:
- Murine models of fat ablation provide valuable insights into the pathogenesis of lipoatrophic diabetes.
- Understanding these mechanisms can inform the development of targeted treatment strategies.
- The contrast between fat deficiency and excess highlights key pathways in metabolic regulation.

